Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac plus magnesium sulfate versus ketorolac plus placebo for pain from intertrochanteric femur fracture
IRCT20120215009014N373Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pain comparing Ketorolac + magnesium sulfate with Ketorolac + placebo (2 arms). Primary endpoint: Pain severity. Started Jul 2020; status: completed.
02
Drugs
ketorolacmagnesium sulfate
03
Conditions
pain
Beyond the preview
Go deeper on IRCT20120215009014N373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N373.